However, at present, biliary tract cancer still depends on TNM staging to judge prognosis and lacks reliable molecular markers.[21]The prognostic value of tumor-infiltrating lymphocytes has attracted increasing attention in an increasing number of tumors, and other cells, except for FoxP3+Tregs, are worthy of further exploration. This evidence concerns the gene FOXP3 and biliary tract neoplasm.